$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000117184321007950 Filed on November 15, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$6.436M	$6.673M	$5.174M
YoY Change	20.64%	28.97%	-47.48%
Cost Of Revenue	$4.251M	$3.598M	$4.041M
YoY Change	4.7%	-10.96%	-26.12%
Gross Profit	$2.185M	$3.075M	$1.133M
YoY Change	71.1%	171.4%	-74.14%
Gross Profit Margin	33.95%	46.08%	21.9%
Selling, General & Admin	$2.837M	$1.981M	$2.237M
YoY Change	35.74%	-11.44%	-15.74%
% of Gross Profit	129.84%	64.42%	197.44%
Research & Development	$313.0K	$244.0K	$305.0K
YoY Change	4.33%	-20.0%	-22.39%
% of Gross Profit	14.32%	7.93%	26.92%
Depreciation & Amortization	$650.0K	$781.0K	$710.0K
YoY Change	-5.8%	10.0%	-1.39%
% of Gross Profit	29.75%	25.4%	62.67%
Operating Expenses	$3.150M	$2.225M	$2.542M
YoY Change	32.35%	-12.47%	-16.6%
Operating Profit	-$965.0K	$850.0K	-$1.409M
YoY Change	-12.98%	-160.33%	-205.62%
Interest Expense	-$17.00K	-$12.00K	-$20.00K
YoY Change	70.0%	-40.0%	-300.0%
% of Operating Profit		-1.41%
Other Income/Expense, Net		$75.00K	-$17.00K
YoY Change		-541.18%	-383.33%
Pretax Income	-$2.057M	$925.0K	-$1.426M
YoY Change	83.66%	-164.87%	-206.42%
Income Tax	-$436.0K	$186.0K	-$319.0K
% Of Pretax Income		20.11%
Net Earnings	-$1.621M	$739.0K	-$1.107M
YoY Change	198.53%	-166.76%	-263.52%
Net Earnings / Revenue	-25.19%	11.07%	-21.4%
Basic Earnings Per Share		$0.13	-$0.20
Diluted Earnings Per Share	-$291.0K	$0.13	-$0.20
COMMON SHARES
Basic Shares Outstanding	5.542M	5.542M	5.526M
Diluted Shares Outstanding		5.626M	5.526M

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.992M	$1.968M	$1.810M
YoY Change	-29.61%	8.73%	-72.11%
Cash & Equivalents	$1.992M	$2.000M	$1.809M
Short-Term Investments
Other Short-Term Assets	$1.499M	$2.754M	$1.300M
YoY Change	64.73%	111.85%	-28.57%
Inventory
Prepaid Expenses
Receivables	$4.116M	$4.681M	$3.890M
Other Receivables	$2.678M	$2.269M	$1.830M
Total Short-Term Assets	$10.29M	$11.67M	$8.831M
YoY Change	7.16%	32.17%	-34.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.691M	$7.296M	$9.746M
YoY Change	-27.52%	-25.14%	6.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$864.0K	$883.0K	$885.0K
YoY Change	-2.7%	-0.23%	-6.25%
Total Long-Term Assets	$11.27M	$11.96M	$15.15M
YoY Change	-21.78%	-21.04%	13.93%
TOTAL ASSETS
Total Short-Term Assets	$10.29M	$11.67M	$8.831M
Total Long-Term Assets	$11.27M	$11.96M	$15.15M
Total Assets	$21.55M	$23.63M	$23.98M
YoY Change	-10.21%	-1.45%	-10.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$994.0K	$448.0K	$416.0K
YoY Change	72.27%	7.69%	11.83%
Accrued Expenses	$3.188M	$3.223M	$1.357M
YoY Change	77.01%	137.51%	-50.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$664.0K	$696.0K	$685.0K
YoY Change	-3.49%	1.61%	64.66%
Total Short-Term Liabilities	$5.830M	$5.342M	$3.342M
YoY Change	47.93%	59.84%	-28.68%
LONG-TERM LIABILITIES
Long-Term Debt	$599.0K	$740.0K	$3.617M
YoY Change	-82.61%	-79.54%	301.89%
Other Long-Term Liabilities	$2.880M	$3.234M	$4.080M
YoY Change	-26.15%	-20.74%	72.88%
Total Long-Term Liabilities	$599.0K	$740.0K	$3.617M
YoY Change	-82.61%	-79.54%	301.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.830M	$5.342M	$3.342M
Total Long-Term Liabilities	$599.0K	$740.0K	$3.617M
Total Liabilities	$9.309M	$9.606M	$11.04M
YoY Change	-18.99%	-12.97%	25.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.550M	-$7.650M	-$8.063M
YoY Change	10.97%	-5.12%	261.25%
Common Stock	$33.51M	$33.39M	$32.72M
YoY Change	2.06%	2.05%	2.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M	$10.08M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$668.0K	$668.0K	$668.0K
Shareholders Equity	$12.24M	$14.03M	$12.94M
YoY Change
Total Liabilities & Shareholders Equity	$21.55M	$23.63M	$23.98M
YoY Change	-10.21%	-1.45%	-10.47%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$1.621M	$739.0K	-$1.107M
YoY Change	198.53%	-166.76%	-263.52%
Depreciation, Depletion And Amortization	$650.0K	$781.0K	$710.0K
YoY Change	-5.8%	10.0%	-1.39%
Cash From Operating Activities	$565.0K	-$388.0K	-$1.490M
YoY Change	-50.44%	-73.96%	-189.22%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	-$68.00K	-$250.0K
YoY Change	-142.86%	-72.8%	-67.11%
Acquisitions
YoY Change
Other Investing Activities	$4.000K	-$50.00K	$20.00K
YoY Change	-120.0%	-350.0%	-133.33%
Cash From Investing Activities	-$26.00K	-$118.0K	-$230.0K
YoY Change	-152.0%	-48.7%	-72.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-515.0K	-177.0K	-170.0K
YoY Change	202.94%	4.12%	-84.4%
NET CHANGE
Cash From Operating Activities	565.0K	-388.0K	-1.490M
Cash From Investing Activities	-26.00K	-118.0K	-230.0K
Cash From Financing Activities	-515.0K	-177.0K	-170.0K
Net Change In Cash	24.00K	-683.0K	-1.890M
YoY Change	-97.65%	-63.86%	656.0%
FREE CASH FLOW
Cash From Operating Activities	$565.0K	-$388.0K	-$1.490M
Capital Expenditures	-$30.00K	-$68.00K	-$250.0K
Free Cash Flow	$595.0K	-$320.0K	-$1.240M
YoY Change	-44.39%	-74.19%	-151.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5542232
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	84000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19024000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16937000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6210000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6205000
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5542000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5537000
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1107000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	993000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3316000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-10000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3316000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1968000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2833000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4681000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3356000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2754000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	914000	USD
CY2021Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2269000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2495000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	11672000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	9598000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7296000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9231000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	883000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	888000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3782000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4286000	USD
CY2021Q3	us-gaap	Assets Assets	23633000	USD
CY2020Q4	us-gaap	Assets Assets	24003000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	448000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	577000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3223000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1801000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	696000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	688000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	975000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	875000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5342000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3941000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	740000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3444000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	290000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	211000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3234000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3895000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	9606000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	11491000	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	33362000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32803000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7650000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8606000	USD
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14027000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23633000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24003000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6673000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5174000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18473000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16025000	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3598000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4041000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10394000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12416000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	3075000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	1133000	USD
	us-gaap	Gross Profit GrossProfit	8079000	USD
	us-gaap	Gross Profit GrossProfit	3609000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1329000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1341000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4138000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4727000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	652000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	896000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1950000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2858000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	244000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	305000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	817000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	981000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2225000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	2542000	USD
	us-gaap	Operating Expenses OperatingExpenses	6905000	USD
	us-gaap	Operating Expenses OperatingExpenses	8566000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	850000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1409000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1174000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4957000	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	USD
CY2021Q3	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	2075000	USD
	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	2075000	USD
CY2021Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	31000	USD
CY2020Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	17000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	44000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	129000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	62000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-129000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	925000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1426000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1236000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5086000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	186000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-319000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	280000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1770000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	739000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1107000	USD
	us-gaap	Net Income Loss NetIncomeLoss	956000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3316000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-10000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	739000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1107000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	956000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3326000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	178000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	739000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14027000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	564000	USD
	us-gaap	Net Income Loss NetIncomeLoss	956000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14027000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	13924000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	126000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	12942000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	16820000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	449000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	12942000	USD
	us-gaap	Net Income Loss NetIncomeLoss	956000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	USD
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	2134000	USD
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1995000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	697000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	713000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-79000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	560000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-94000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	564000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	449000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1325000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	110000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1840000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1344000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-226000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-129000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-204000	USD
	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-754000	USD
	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-721000	USD
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	1422000	USD
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-2219000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-151000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5223000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	140000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	880000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	84000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	184000	USD
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	42000	USD
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	-10000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-194000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-914000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-5000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-8000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2181000	USD
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	515000	USD
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	507000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	993000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-520000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	673000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-865000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5474000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2833000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7283000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1968000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1809000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	236000	USD
	us-gaap	Interest Paid Net InterestPaidNet	40000	USD
	us-gaap	Interest Paid Net InterestPaidNet	60000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	862000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	800000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	193000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2346000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3000	USD
CY2021Q3	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	800000	USD
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	2500000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000.0	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	178000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	126000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	564000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	449000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5522000
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	545000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	547000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5522000
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	84000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	72000
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5626000
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5526000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5614000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	604000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.31
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.47
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	575000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	147000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	464000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5542000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5526000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5542000
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3800000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4200000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039	pure
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	269000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	807000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	243000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1117000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1118000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1034000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	544000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	509000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4565000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	356000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4209000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	975000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3234000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4209000	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2.1	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	740000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6673000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5174000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18473000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16025000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6673000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5174000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18473000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16025000	USD

Files In Submission

Name	View Source	Status
0001171843-21-007950-index-headers.html	Edgar Link	pending
0001171843-21-007950-index.html	Edgar Link	pending
0001171843-21-007950.txt	Edgar Link	pending
0001171843-21-007950-xbrl.zip	Edgar Link	pending
ex_303650.htm	Edgar Link	pending
ex_303651.htm	Edgar Link	pending
ex_303652.htm	Edgar Link	pending
ex_303653.htm	Edgar Link	pending
ex_306331.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmd-20210930.xsd	Edgar Link	pending
pmd-20210930_cal.xml	Edgar Link	unprocessable
pmd-20210930_def.xml	Edgar Link	unprocessable
pmd-20210930_lab.xml	Edgar Link	unprocessable
pmd-20210930_pre.xml	Edgar Link	unprocessable
pmd20210930_10q.htm	Edgar Link	pending
pmd20210930_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2021 Q4 Form 10-Q Financial Statement

#000117184321007950 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2021 Q4 Form 10-Q Financial Statement

#000117184321007950 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi